Skip to main content
EyeGene,Inc logo

EyeGene,Inc — Investor Relations & Filings

Ticker · 185490 ISIN · KR7185490000 KO Professional, scientific and technical activities
Open in API
Filings indexed 314 across all filing types
Latest filing 2024-01-03 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 185490

About EyeGene,Inc

https://eyegene.co.kr/en/

EyeGene, Inc. is a clinical-stage biopharmaceutical company that researches and develops innovative therapeutics, with a primary focus on gene and cell therapy for age-related diseases. The company's pipeline includes EG-Mirotin, a treatment candidate for non-proliferative diabetic retinopathy and dry age-related macular degeneration. EyeGene is also developing preventive vaccines, such as EG-HPV for cervical cancer, utilizing its proprietary EG-Vac adjuvant system to enhance vaccine efficacy. The company is dedicated to creating transformative treatments by advancing biomedical science.

Recent filings

Filing Released Lang Actions
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the granting of stock options (주식매수선택권 부여). It details the number of shares, exercise price, grant date, and the board resolution details. Since this is a specific regulatory disclosure regarding capital structure and equity-based compensation, it falls under the 'Regulatory Filings' category as it does not fit into the specific categories for director dealings (which are usually personal trades) or share issues (which are usually capital increases).
2024-01-03 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company '아이진' (Eyegene). It details the date, location, and specific agenda items, which include the appointment of directors and the approval of stock options. This type of document, which provides information to shareholders regarding an upcoming meeting and requests their participation/votes, is classified as a Proxy Solicitation & Information Statement (PSI).
2024-01-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically regarding major shareholders, special relationships, and changes in control (e.g., '경영권에 영향을 주기 위한 목적'). This type of filing is categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-01-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when an entity or individual acquires a significant stake (typically 5% or more) in a company. This document details the shareholding status, the purpose of holding (management influence), and changes in share ownership for 'Eyegene Inc.' by 'BMI Korea Co., Ltd.' and its special related parties. This falls under the 'Major Shareholding Notification' category.
2024-01-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details a change in shareholding by a major shareholder (BMI Korea) in the company Eyegene, specifically noting a change in status to a major shareholder following a third-party capital increase. This type of filing is a standard regulatory disclosure for insider or major shareholder transactions, which falls under the 'Director's Dealing' (DIRS) category in the provided schema, as it pertains to the reporting of share ownership changes by major stakeholders.
2024-01-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by corporate insiders to disclose their shareholdings and changes in ownership. This falls under the category of 'Director's Dealing' (DIRS) as it reports personal share transactions and ownership status by company executives.
2024-01-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.